NEW RITE AID, LLC
riteaid.comNo Longer Reporting
The company has not filed an annual or quarterly report since its Q2 FY2024 10-Q, filed Oct 18, 2023. Its latest SEC filing is a 15-12G from Mar 3, 2025.
10-Q for Q2 FY2024, filed Oct 18, 2023
The sections below describe the company as of the FY2023 annual report.
What Did They Do?
Sells prescription drugs and health products through retail pharmacies, provides pharmacist-delivered care, and offers pharmacy-benefit and mail services to individuals, health plans and other benefit sponsors.
10-K for FY2023, filed May 1, 2023Retail Pharmacy Segment — In our retail stores, our highly trained pharmacists dispense medications pursuant to prescriptions written by…View ↗
In fiscal 2023, prescription drug sales accounted for over 71% of our total drugstore sales. We believe that our pharmacy operations will…View ↗
Pharmacy Services Segment — Elixir, our mid-market national PBM, provides a suite of PBM offerings including technology solutions, mail…View ↗
Who Were Their Customers?
Retail customers buy prescriptions and other health products in Rite Aid stores; health plans and government payors cover eligible prescriptions. Elixir serves employers, insurers, unions, government groups and health plans.
10-K for FY2023, filed May 1, 2023Retail Pharmacy Segment — In our retail stores, our highly trained pharmacists dispense medications pursuant to prescriptions written by…View ↗
In fiscal 2023, substantially all of our pharmacy sales were to customers covered by third-party payors (such as insurance companies…View ↗
Through our Pharmacy Services Segment we provide innovative pharmaceutical solutions for our clients which are primarily employers…View ↗
How Were They Changing?
- Net income
-
Sources
10-Q for Q2 FY2024, filed Oct 18, 2023
−$1BView ↗
- ▲ +208% (Loss)
- vs −$331.3M in Q2 FY2023
10-Q/A, filed Jul 25, 2024
Open tableView ↗
-
Feb 6, 2024
Rite Aid completed the sale of Elixir to MedImpact
The transaction disposed of substantially all Elixir assets; consideration included term loans and cash.
Sources
8-K, filed Feb 6, 2024
As previously disclosed in the Company’s current report on Form 8-K filed on October 16, 2023, Hunter Lane, LLC, a subsidiary of the…View ↗
-
Oct 19, 2023
Jeffrey Stein replaced Busy Burr as CEO
Stein also became chief restructuring officer and joined the board.
Sources
8-K, filed Oct 19, 2023
PHILADELPHIA — Oct. 15, 2023 — Rite Aid Corporation (NYSE: RAD) (“Rite Aid” or the “Company”) today announced that its Board of Directors…View ↗
-
Oct 16, 2023
Rite Aid and subsidiaries filed for Chapter 11
The debtors said they would continue operating under the bankruptcy court's jurisdiction.
Sources
8-K, filed Oct 16, 2023
On October 15, 2023 (the “Petition Date”), Rite Aid Corporation (“Rite Aid” or the “Company”) and certain of its direct and indirect…View ↗
Bartell added
The retail segment includes Bartell stores, added through an acquisition, alongside Rite Aid and Health Dialog; the older report's segment description instead listed RediClinic.
10-K for FY2020, filed Apr 27, 2020 10-K for FY2023, filed May 1, 2023In fiscal 2020, we continued reporting our business in two distinct segments. Our Retail Pharmacy Segment consists of Rite Aid stores…View ↗
Who Did They Compete With?
Competes with Walgreens, CVS, Kroger, Walmart, Target, Caremark, Express Scripts, and OptumRx
10-K for FY2023, filed May 1, 2023Our retail drugstore operations compete with, among others, retail drugstore chains, such as Walgreens and CVS, along with independently…View ↗
Loading...
